2019 Q3 Form 10-Q Financial Statement
#000156459019040522 Filed on November 06, 2019
Income Statement
| Concept | 2019 Q3 | 2018 Q3 |
|---|---|---|
| Revenue | $186.3M | $202.3M |
| YoY Change | -7.91% | 6.36% |
| Cost Of Revenue | $49.70M | $49.70M |
| YoY Change | 0.0% | 37.29% |
| Gross Profit | $136.6M | $152.6M |
| YoY Change | -10.48% | -0.91% |
| Gross Profit Margin | 73.32% | 75.43% |
| Selling, General & Admin | $135.5M | $129.9M |
| YoY Change | 4.31% | 21.18% |
| % of Gross Profit | 99.19% | 85.12% |
| Research & Development | $21.30M | $21.10M |
| YoY Change | 0.95% | 18.54% |
| % of Gross Profit | 15.59% | 13.83% |
| Depreciation & Amortization | $2.900M | $4.900M |
| YoY Change | -40.82% | 25.64% |
| % of Gross Profit | 2.12% | 3.21% |
| Operating Expenses | $156.8M | $151.0M |
| YoY Change | 3.84% | 20.8% |
| Operating Profit | -$20.90M | $1.200M |
| YoY Change | -1841.67% | -98.57% |
| Interest Expense | $2.900M | $2.200M |
| YoY Change | 31.82% | 144.44% |
| % of Operating Profit | 183.33% | |
| Other Income/Expense, Net | -$1.400M | -$400.0K |
| YoY Change | 250.0% | -50.0% |
| Pretax Income | -$22.30M | $800.0K |
| YoY Change | -2887.5% | -99.04% |
| Income Tax | -$1.700M | $1.600M |
| % Of Pretax Income | 200.0% | |
| Net Earnings | -$20.60M | -$700.0K |
| YoY Change | 2842.86% | -100.89% |
| Net Earnings / Revenue | -11.06% | -0.35% |
| Basic Earnings Per Share | -$0.28 | -$0.01 |
| Diluted Earnings Per Share | -$0.28 | -$0.01 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 73.70M shares | 73.00 |
| Diluted Shares Outstanding | 73.70M shares | 73.00 |
Balance Sheet
| Concept | 2019 Q3 | 2018 Q3 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $142.6M | $167.5M |
| YoY Change | -14.87% | 12.95% |
| Cash & Equivalents | $89.90M | $93.30M |
| Short-Term Investments | $52.70M | $74.20M |
| Other Short-Term Assets | $37.00M | $15.10M |
| YoY Change | 145.03% | -17.49% |
| Inventory | $28.10M | $35.90M |
| Prepaid Expenses | ||
| Receivables | $117.0M | $119.1M |
| Other Receivables | $4.800M | $4.300M |
| Total Short-Term Assets | $329.5M | $341.9M |
| YoY Change | -3.63% | 5.01% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $55.00M | $59.10M |
| YoY Change | -6.94% | 18.67% |
| Goodwill | $416.1M | |
| YoY Change | ||
| Intangibles | $667.8M | |
| YoY Change | ||
| Long-Term Investments | $51.50M | $24.20M |
| YoY Change | 112.81% | -51.7% |
| Other Assets | ||
| YoY Change | ||
| Total Long-Term Assets | $1.262B | $1.232B |
| YoY Change | 2.44% | 36.45% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $329.5M | $341.9M |
| Total Long-Term Assets | $1.262B | $1.232B |
| Total Assets | $1.591B | $1.574B |
| YoY Change | 1.12% | 28.11% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $24.00M | $23.80M |
| YoY Change | 0.84% | 5.78% |
| Accrued Expenses | $73.00M | $47.80M |
| YoY Change | 52.72% | 28.49% |
| Deferred Revenue | $2.100M | $2.500M |
| YoY Change | -16.0% | -13.79% |
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $115.4M | $108.0M |
| YoY Change | 6.85% | -22.41% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $225.0M | $258.0M |
| YoY Change | -12.79% | 247.71% |
| Other Long-Term Liabilities | $7.300M | $6.300M |
| YoY Change | 15.87% | -14.86% |
| Total Long-Term Liabilities | $232.3M | $264.3M |
| YoY Change | -12.11% | 3471.62% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $115.4M | $108.0M |
| Total Long-Term Liabilities | $232.3M | $264.3M |
| Total Liabilities | $516.7M | $471.4M |
| YoY Change | 9.61% | 31.9% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | ||
| YoY Change | ||
| Common Stock | ||
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $1.075B | $1.102B |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $1.591B | $1.574B |
| YoY Change | 1.12% | 28.11% |
Cashflow Statement
| Concept | 2019 Q3 | 2018 Q3 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$20.60M | -$700.0K |
| YoY Change | 2842.86% | -100.89% |
| Depreciation, Depletion And Amortization | $2.900M | $4.900M |
| YoY Change | -40.82% | 25.64% |
| Cash From Operating Activities | $15.80M | $7.800M |
| YoY Change | 102.56% | -66.81% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | -$1.400M | -$1.300M |
| YoY Change | 7.69% | -18.75% |
| Acquisitions | $279.6M | |
| YoY Change | ||
| Other Investing Activities | -$5.700M | -$277.7M |
| YoY Change | -97.95% | 1941.91% |
| Cash From Investing Activities | -$7.100M | -$279.0M |
| YoY Change | -97.46% | 1735.53% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | -$12.30M | 252.1M |
| YoY Change | -104.88% | -1181.97% |
| NET CHANGE | ||
| Cash From Operating Activities | $15.80M | 7.800M |
| Cash From Investing Activities | -$7.100M | -279.0M |
| Cash From Financing Activities | -$12.30M | 252.1M |
| Net Change In Cash | -$3.300M | -17.60M |
| YoY Change | -81.25% | 17.33% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | $15.80M | $7.800M |
| Capital Expenditures | -$1.400M | -$1.300M |
| Free Cash Flow | $17.20M | $9.100M |
| YoY Change | 89.01% | -63.75% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2019Q3 | us-gaap |
Revenue Practical Expedient Remaining Performance Obligation
RevenuePracticalExpedientRemainingPerformanceObligation
|
true | |
| CY2019Q3 | us-gaap |
Revenue Practical Expedient Initial Application And Transition Nondisclosure Of Transaction Price Allocation To Remaining Performance Obligation
RevenuePracticalExpedientInitialApplicationAndTransitionNondisclosureOfTransactionPriceAllocationToRemainingPerformanceObligation
|
true | |
| CY2019Q3 | us-gaap |
Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
|
true | |
| CY2019Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
|
Options and restricted stock units granted to our non-employee directors vest in full upon completion of one year of service on the Board following the date of the grant. | |
| CY2018Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1100000 | |
| CY2019Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1400000 | |
| CY2018Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-400000 | |
| CY2018Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
800000 | |
| CY2019Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.28 | |
| CY2019Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.28 | |
| CY2019Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1562700000 | |
| CY2019Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
186300000 | |
| CY2018Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
202300000 | |
| CY2019Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
600000 | |
| CY2018Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
21100000 | |
| CY2019Q2 | mygn |
Liabilities Other Than Long Term Debt Noncurrent Excluding Business Combination Contingent Consideration Liability Noncurrent
LiabilitiesOtherThanLongTermDebtNoncurrentExcludingBusinessCombinationContingentConsiderationLiabilityNoncurrent
|
7800000 | |
| CY2019Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
73500000 | |
| CY2019Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
1088900000 | |
| CY2018Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
| CY2019Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
73700000 | |
| CY2018Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-700000 | |
| CY2018Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-500000 | |
| CY2018Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
966100000 | |
| CY2019Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
8800000 | |
| CY2019Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-20600000 | |
| CY2018Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
73000000.0 | |
| CY2019Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
73700000 | |
| CY2018Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
73000000.0 | |
| CY2019Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-20600000 | |
| CY2019Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
0 | |
| CY2018Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-200000 | |
| CY2019Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-2200000 | |
| CY2018Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
400000 | |
| CY2019Q3 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-22800000 | |
| CY2018Q3 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-500000 | |
| CY2019Q3 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
0 | |
| CY2018Q3 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
0 | |
| CY2019Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-22800000 | |
| CY2018Q3 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
1900000 | |
| CY2018Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
127400000 | |
| CY2018Q3 | us-gaap |
Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
|
7700000 | |
| CY2018Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-200000 | |
| CY2018Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
1102200000 | |
| CY2019Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
1088900000 | |
| CY2019Q3 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
-500000 | |
| CY2019Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-2100000 | |
| CY2019Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
1074500000 | |
| CY2018Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-700000 | |
| CY2019Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
18200000 | |
| CY2018Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
18300000 | |
| CY2019Q3 | mygn |
Non Cash Interest Expense
NonCashInterestExpense
|
100000 | |
| CY2018Q3 | mygn |
Non Cash Interest Expense
NonCashInterestExpense
|
-1300000 | |
| CY2019Q3 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
100000 | |
| CY2018Q3 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
1000000.0 | |
| CY2019Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
8800000 | |
| CY2018Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
7700000 | |
| CY2019Q3 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
5100000 | |
| CY2019Q3 | mygn |
Increase Decrease In Unrecognized Tax Benefits
IncreaseDecreaseInUnrecognizedTaxBenefits
|
-400000 | |
| CY2018Q3 | mygn |
Increase Decrease In Unrecognized Tax Benefits
IncreaseDecreaseInUnrecognizedTaxBenefits
|
2600000 | |
| CY2019Q3 | mygn |
Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
|
700000 | |
| CY2018Q3 | mygn |
Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
|
-400000 | |
| CY2019Q3 | mygn |
Increase Decrease In Prepaid Expense Excluding Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes
|
-2600000 | |
| CY2018Q3 | mygn |
Increase Decrease In Prepaid Expense Excluding Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes
|
-1800000 | |
| CY2018Q3 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-200000 | |
| CY2019Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
15800000 | |
| CY2018Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
7800000 | |
| CY2019Q3 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
1400000 | |
| CY2018Q3 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
279600000 | |
| CY2019Q3 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
23100000 | |
| CY2018Q3 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
14400000 | |
| CY2019Q3 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
17400000 | |
| CY2018Q3 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
16300000 | |
| CY2019Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-7100000 | |
| CY2018Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-279000000.0 | |
| CY2019Q3 | mygn |
Proceeds From Repayments Of Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromRepaymentsOfIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
-400000 | |
| CY2018Q3 | mygn |
Proceeds From Repayments Of Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromRepaymentsOfIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
2100000 | |
| CY2019Q3 | us-gaap |
Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
|
3300000 | |
| CY2018Q3 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
290000000.0 | |
| CY2019Q3 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
8600000 | |
| CY2018Q3 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
40000000.0 | |
| CY2019Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-12300000 | |
| CY2018Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
252100000 | |
| CY2019Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-3300000 | |
| CY2018Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-17600000 | |
| CY2019Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
93200000 | |
| CY2018Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
110900000 | |
| CY2019Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
89900000 | |
| CY2018Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
93300000 | |
| CY2019Q3 | us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:4.46%;white-space:nowrap" valign="top"> <p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(1)</span></p></td> <td valign="top"> <p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">BASIS OF PRESENTATION</p></td></tr></table></div> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.46%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying condensed consolidated financial statements have been prepared by Myriad Genetics, Inc. (the “Company” or “Myriad”) in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (“SEC”). The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with GAAP. The condensed consolidated financial statements herein should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2019, included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019. Operating results for the three months ended September 30, 2019 may not necessarily be indicative of results to be expected for any other interim period or for the full year.</p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.46%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements include the accounts of the Company’s majority-owned subsidiary, Assurex Canada, Ltd. which is 85% owned by Assurex Health, Inc. (“Assurex”), a wholly owned subsidiary of the Company, and 15% owned by the Centre for Addiction and Mental Health. Assurex Canada, Ltd. is a consolidated subsidiary of Assurex Health, Inc. The value of the non-controlling interest represents the portion of Assurex Canada, Ltd.’s profit or loss and net assets that is not held by Assurex Health, Inc. The Company attributes comprehensive income or loss of the subsidiary between the Company and the non-controlling interest based on the respective ownership interest.</p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.46%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:4.46%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.46%;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Recently Adopted Standards </p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.46%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2016, the FASB issued ASU 2016-02, Leases (“ASU 2016-02”). ASU 2016-02 amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and changing certain lessor accounting requirements. ASU 2016-02 also requires entities to provide enhanced disclosures surrounding the amount, timing and uncertainty of cash flows arising from leasing arrangements. On July 1, 2019, the Company adopted ASU 2016-02 under the modified retrospective approach by initially applying ASU 2016-02 at the adoption date, rather than at the beginning of the earliest comparative period presented. Results for the three months ended September 30, 2019 are presented under ASU 2016-02. Prior period amounts were not adjusted and continue to be reported under previous lease accounting guidance.</p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.46%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under ASU 2016-02, the Company determines if an arrangement is or contains a lease at inception by assessing whether the arrangement contains an identified asset and whether it has the right to control the identified asset. Right-of-use (“ROU”) assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease. Lease liabilities are recognized at the lease commencement date based on the present value of future lease payments over the lease term. ROU assets are based on the measurement of the lease liability and also include any lease payments made prior to or on lease commencement and exclude lease incentives and initial direct costs incurred, as applicable.</p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.46%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As the implicit rate in the Company's leases is generally unknown, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of future lease payments. When calculating the Company’s incremental borrowing rates, the Company gives consideration to its credit risk, term of the lease, total lease payments and adjust for the impacts of collateral, as necessary. The lease term used may reflect any option to extend or terminate the lease when it is reasonably certain the Company will exercise such options. Lease expenses for the Company's operating leases are recognized on a straight-line basis over the lease term.</p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.46%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ASU 2016-02 provides a number of optional practical expedients in transitioning to ASU 2016-02. The Company has elected the package of practical expedients to avoid reassessing under ASU 2016-02 prior conclusions about lease identification, lease classification and initial direct costs. The Company has also elected the practical expedient allowing the use of hindsight in determining the lease term and assessing impairment of right-of-use ROU assets based on all facts and circumstances through the effective date of the new standard. ASU 2016-02 also provides practical expedients for ongoing lease accounting. The Company has elected the recognition exemption for short-term leases for all leases that qualify. Under this exemption, the Company will not recognize ROU assets or lease liabilities for those leases that qualify as a short-term lease (leases with lease terms of 12 months or less), which includes not recognizing ROU assets or lease liabilities for existing short-term leases in transition. The Company also has elected the practical expedient avoid separating lease and non-lease components for any of its leases within its existing classes of assets.</p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.46%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognized operating lease liabilities of $78.8 and right-of-use assets related to operating leases totaling $74.5 as of the adoption date. These are presented as “Current maturities of operating lease liabilities” for a total of $13.1, “Noncurrent operating lease liabilities” for a total of $65.7, and “Operating lease right-of-use assets” for a total of $74.5 on the Company’s consolidated balance sheet. <span style="color:#000000;">No adjustments to the beginning retained earnings balance were required.</span></p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:4.46%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:8pt;margin-bottom:0pt;margin-left:4.46%;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Standards Effective in Future Years and Not Yet Adopted</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:4.46%;text-indent:0%;font-size:6pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:4.46%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326) (“ASU 2016-13”) which introduces new guidance for the accounting for credit losses on certain instruments within its scope. ASU 2016-13 introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. For trade receivables, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses, which reflects losses that are probable. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. ASU 2016-13 is effective for fiscal years beginning after December 31, 2019, including interim periods within those years. Early application of the guidance is permitted for all entities for fiscal years beginning after December 15, 2018, including the interim periods within those fiscal years. Application of the amendments is through a cumulative-effect adjustment to retained earnings as of the effective date. The Company is currently evaluating the impact of ASU 2016-13 on its consolidated financial statements<span style="color:#000000;">.</span></p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:4.46%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> | |
| CY2019Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
186300000 | |
| CY2018Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
202300000 | |
| CY2019Q2 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
2200000 | |
| CY2018Q2 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
2600000 | |
| CY2019Q3 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
400000 | |
| CY2018Q3 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
1700000 | |
| CY2019Q3 | mygn |
Contract With Customer Liability Prepayments
ContractWithCustomerLiabilityPrepayments
|
300000 | |
| CY2018Q3 | mygn |
Contract With Customer Liability Prepayments
ContractWithCustomerLiabilityPrepayments
|
1600000 | |
| CY2019Q3 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
2100000 | |
| CY2018Q3 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
2500000 | |
| CY2019Q3 | us-gaap |
Revenue Practical Expedient Remaining Performance Obligation Description
RevenuePracticalExpedientRemainingPerformanceObligationDescription
|
In accordance with ASU 2014-09, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its contracts that are one year or less, as the revenue is expected to be recognized within the next year. Furthermore, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its agreements wherein the Company’s right to payment is in an amount that directly corresponds with the value of Company’s performance to date. However, periodically the Company enters into arrangements with customers to provide diagnostic testing and/or pharmaceutical and clinical services that may have terms longer than one year and include multiple performance obligations. | |
| CY2019Q3 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
1800000 | |
| CY2019Q3 | us-gaap |
Capitalized Contract Cost Gross
CapitalizedContractCostGross
|
0 | |
| CY2019Q3 | us-gaap |
Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
|
This practical expedient has been elected because the Company collects very little cash from customers under payment terms and vast majority of payments terms have a payback period of less than one year. | |
| CY2019Q3 | mygn |
Revenue Increase Decrease Reduction Performance Obligation
RevenueIncreaseDecreaseReductionPerformanceObligation
|
-10900000 | |
| CY2019Q3 | mygn |
Earnings Per Share Increase Decrease Reduction Performance Obligation
EarningsPerShareIncreaseDecreaseReductionPerformanceObligation
|
-0.11 | |
| CY2019Q3 | us-gaap |
Investments And Cash
InvestmentsAndCash
|
193500000 | |
| CY2019Q3 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
193500000 | |
| CY2019Q3 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
600000 | |
| CY2019Q3 | mygn |
Investments And Cash At Fair Value
InvestmentsAndCashAtFairValue
|
194100000 | |
| CY2019Q3 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
194100000 | |
| CY2019Q2 | us-gaap |
Investments And Cash
InvestmentsAndCash
|
191200000 | |
| CY2019Q2 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
191200000 | |
| CY2019Q2 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
600000 | |
| CY2019Q2 | mygn |
Investments And Cash At Fair Value
InvestmentsAndCashAtFairValue
|
191800000 | |
| CY2019Q2 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
191800000 | |
| CY2019Q3 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
|
0 | |
| CY2019Q3 | us-gaap |
Buildings And Improvements Gross
BuildingsAndImprovementsGross
|
18200000 | |
| CY2019Q2 | us-gaap |
Buildings And Improvements Gross
BuildingsAndImprovementsGross
|
18800000 | |
| CY2019Q3 | us-gaap |
Leasehold Improvements Gross
LeaseholdImprovementsGross
|
31100000 | |
| CY2019Q3 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
54900000 | |
| CY2019Q3 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
55000000.0 | |
| CY2019Q3 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
48700000 | |
| CY2019Q3 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
49200000 | |
| CY2019Q3 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
|
0 | |
| CY2019Q3 | us-gaap |
Investments And Cash
InvestmentsAndCash
|
193500000 | |
| CY2019Q3 | mygn |
Investments And Cash At Fair Value
InvestmentsAndCashAtFairValue
|
194100000 | |
| CY2019Q3 | us-gaap |
Land
Land
|
2200000 | |
| CY2019Q2 | us-gaap |
Land
Land
|
2300000 | |
| CY2019Q2 | us-gaap |
Leasehold Improvements Gross
LeaseholdImprovementsGross
|
31000000.0 | |
| CY2019Q3 | us-gaap |
Machinery And Equipment Gross
MachineryAndEquipmentGross
|
115500000 | |
| CY2019Q2 | us-gaap |
Machinery And Equipment Gross
MachineryAndEquipmentGross
|
117100000 | |
| CY2019Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
167000000.0 | |
| CY2019Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
169200000 | |
| CY2019Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
112000000.0 | |
| CY2019Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
111900000 | |
| CY2019Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
55000000.0 | |
| CY2019Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
57300000 | |
| CY2019Q3 | us-gaap |
Depreciation
Depreciation
|
2900000 | |
| CY2018Q3 | us-gaap |
Depreciation
Depreciation
|
4900000 | |
| CY2019Q3 | us-gaap |
Goodwill
Goodwill
|
416100000 | |
| CY2019Q2 | us-gaap |
Goodwill
Goodwill
|
417200000 | |
| CY2019Q3 | us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
-1100000 | |
| CY2019Q3 | us-gaap |
Goodwill
Goodwill
|
416100000 | |
| CY2019Q3 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
822200000 | |
| CY2019Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
176700000 | |
| CY2019Q3 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
645500000 | |
| CY2019Q3 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
22300000 | |
| CY2019Q3 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
22300000 | |
| CY2019Q3 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
844500000 | |
| CY2019Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
176700000 | |
| CY2019Q3 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
667800000 | |
| CY2019Q2 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
823300000 | |
| CY2019Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
161600000 | |
| CY2019Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
661700000 | |
| CY2019Q2 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
23000000.0 | |
| CY2019Q2 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
23000000.0 | |
| CY2019Q2 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
846300000 | |
| CY2019Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
161600000 | |
| CY2019Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
684700000 | |
| CY2019Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
15300000 | |
| CY2018Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
13400000 | |
| CY2019Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
45200000 | |
| CY2019Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
48800000 | |
| CY2019Q3 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
7200000 | |
| CY2019Q2 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
3000000.0 | |
| CY2019Q3 | us-gaap |
Litigation Reserve Current
LitigationReserveCurrent
|
9100000 | |
| CY2019Q2 | us-gaap |
Litigation Reserve Current
LitigationReserveCurrent
|
9100000 | |
| CY2019Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
11500000 | |
| CY2019Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
18000000.0 | |
| CY2019Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
73000000.0 | |
| CY2019Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
78900000 | |
| CY2019Q3 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
226600000 | |
| CY2019Q2 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
235000000.0 | |
| CY2019Q3 | us-gaap |
Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
|
1600000 | |
| CY2019Q2 | us-gaap |
Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
|
1500000 | |
| CY2019Q3 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
225000000.0 | |
| CY2019Q2 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
233500000 | |
| CY2019Q3 | us-gaap |
Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
|
6800000 | |
| CY2019Q2 | us-gaap |
Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
|
6800000 | |
| CY2019Q3 | mygn |
Other Liabilities Noncurrent Other
OtherLiabilitiesNoncurrentOther
|
500000 | |
| CY2019Q2 | mygn |
Other Liabilities Noncurrent Other
OtherLiabilitiesNoncurrentOther
|
1000000.0 | |
| CY2019Q3 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
7300000 | |
| CY2019Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
7800000 | |
| CY2019Q3 | mygn |
Number Of Defined Benefit Pension Plans
NumberOfDefinedBenefitPensionPlans
|
2 | |
| CY2019Q3 | us-gaap |
Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
|
100000 | |
| CY2019Q3 | us-gaap |
Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
|
6800000 | |
| CY2019Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000.0 | |
| CY2019Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2019Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2019Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000.0 | |
| CY2019Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2019Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
74400000 | |
| CY2019Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
74400000 | |
| CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
11900000 | |
| CY2019Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
73500000 | |
| CY2019Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
73500000 | |
| CY2018Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
70600000 | |
| CY2018Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
70600000 | |
| CY2019Q3 | us-gaap |
Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
|
900000 | |
| CY2019 | us-gaap |
Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
|
4500000 | |
| CY2019 | us-gaap |
Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
|
1600000 | |
| CY2019Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
74400000 | |
| CY2019Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
74400000 | |
| CY2019Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
73500000 | |
| CY2019Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
73500000 | |
| CY2019Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
73700000 | |
| CY2018Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
73000000.0 | |
| CY2019Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
73700000 | |
| CY2018Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
73000000.0 | |
| CY2019Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1700000 | |
| CY2018Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4100000 | |
| CY2019Q3 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
|
110700000 | |
| CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
14900000 | |
| CY2019Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-1700000 | |
| CY2019Q3 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.076 | |
| CY2018Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1600000 | |
| CY2018Q3 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
2.000 | |
| CY2019Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5500000 | |
| CY2019Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
24.45 | |
| CY2019Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
0 | |
| CY2019Q3 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2019Q3 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
400000 | |
| CY2019Q3 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
22.87 | |
| CY2019Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
100000 | |
| CY2019Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
30.00 | |
| CY2019Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5000000.0 | |
| CY2019Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
24.39 | |
| CY2019Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
5000000.0 | |
| CY2019Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
24.39 | |
| CY2019Q3 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
0 | |
| CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
84700000 | |
| CY2019Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
8800000 | |
| CY2018Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
7700000 | |
| CY2019Q3 | us-gaap |
Fair Value Net Asset Liability
FairValueNetAssetLiability
|
108300000 | |
| CY2019Q2 | us-gaap |
Fair Value Net Asset Liability
FairValueNetAssetLiability
|
104500000 | |
| CY2019Q2 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
13800000 | |
| CY2019Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
|
3300000 | |
| CY2019Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
|
-700000 | |
| CY2019Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
|
900000 | |
| CY2019Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
10700000 | |
| CY2019Q3 | us-gaap |
Loss Contingency Settlement Agreement Date
LossContingencySettlementAgreementDate
|
July 18, 2019 | |
| CY2019Q3 | us-gaap |
Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
|
9100000 | |
| CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
13700000 | |
| CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
12600000 | |
| CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
12300000 | |
| CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
19300000 | |
| CY2019Q3 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P6Y | |
| CY2019Q3 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0387 | |
| CY2019Q2 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
15100000 | |
| CY2019Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
14100000 | |
| CY2019Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
13100000 | |
| CY2019Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
12200000 | |
| CY2019Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
11900000 | |
| CY2019Q2 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
19100000 | |
| CY2019Q2 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
85500000 | |
| CY2019Q3 | mygn |
Percent Of Employee Contribution To Deferred Savings Plan
PercentOfEmployeeContributionToDeferredSavingsPlan
|
0.50 | |
| CY2019Q3 | mygn |
Employers Contribution Not To Exceed Percentage Of Employees Compensation
EmployersContributionNotToExceedPercentageOfEmployeesCompensation
|
0.04 | |
| CY2019Q3 | us-gaap |
Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
|
2500000 | |
| CY2018Q3 | us-gaap |
Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
|
2000000.0 | |
| CY2019Q3 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
2 | |
| CY2019Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
186300000 | |
| CY2019Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
18200000 | |
| CY2019Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-20900000 | |
| CY2018Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
202300000 | |
| CY2018Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
18300000 | |
| CY2018Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1200000 | |
| CY2019Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-20900000 | |
| CY2018Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1200000 | |
| CY2019Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
900000 | |
| CY2018Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
700000 | |
| CY2019Q3 | us-gaap |
Interest Expense
InterestExpense
|
2900000 | |
| CY2018Q3 | us-gaap |
Interest Expense
InterestExpense
|
2200000 | |
| CY2019Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
600000 | |
| CY2018Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1100000 | |
| CY2019Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-22300000 | |
| CY2018Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
800000 | |
| CY2019Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-1700000 | |
| CY2018Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1600000 | |
| CY2019Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-20600000 | |
| CY2018Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-800000 | |
| CY2018Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-100000 | |
| CY2019Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-20600000 | |
| CY2018Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-700000 | |
| CY2019Q3 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
200000 | |
| CY2018Q3 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
4900000 | |
| CY2019Q3 | us-gaap |
Interest Paid Net
InterestPaidNet
|
2800000 | |
| CY2018Q3 | us-gaap |
Interest Paid Net
InterestPaidNet
|
900000 | |
| CY2019Q3 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
4300000 |
